These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11316893)

  • 1. A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins.
    Lee DC; Stenland CJ; Miller JL; Cai K; Ford EK; Gilligan KJ; Hartwell RC; Terry JC; Rubenstein R; Fournel M; Petteway SR
    Transfusion; 2001 Apr; 41(4):449-55. PubMed ID: 11316893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partitioning of human and sheep forms of the pathogenic prion protein during the purification of therapeutic proteins from human plasma.
    Stenland CJ; Lee DC; Brown P; Petteway SR; Rubenstein R
    Transfusion; 2002 Nov; 42(11):1497-500. PubMed ID: 12421224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring plasma processing steps with a sensitive Western blot assay for the detection of the prion protein.
    Lee DC; Stenland CJ; Hartwell RC; Ford EK; Cai K; Miller JL; Gilligan KJ; Rubenstein R; Fournel M; Petteway SR
    J Virol Methods; 2000 Jan; 84(1):77-89. PubMed ID: 10644089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation.
    Berardi VA; Cardone F; Valanzano A; Lu M; Pocchiari M
    Transfusion; 2006 Apr; 46(4):652-8. PubMed ID: 16584444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solvent-dependent precipitation of prion protein.
    Cai K; Miller JL; Stenland CJ; Gilligan KJ; Hartwell RC; Terry JC; Evans-Storms RB; Rubenstein R; Petteway SR; Lee DC
    Biochim Biophys Acta; 2002 May; 1597(1):28-35. PubMed ID: 12009399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High titers of transmissible spongiform encephalopathy infectivity associated with extremely low levels of PrPSc in vivo.
    Barron RM; Campbell SL; King D; Bellon A; Chapman KE; Williamson RA; Manson JC
    J Biol Chem; 2007 Dec; 282(49):35878-86. PubMed ID: 17923484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TSE clearance during plasma products separation process by Gradiflow(TM).
    Wang K; Johnson A; Obradovic M; Anderson G; Maclean C; Nair H
    Biologicals; 2005 Jun; 33(2):87-94. PubMed ID: 15939286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation between transmissible spongiform encephalopathy (TSE) infectivity and proteinase K-resistant PrP(Sc) levels in peripheral tissue from a murine transgenic model of TSE disease.
    Dobie K; Barron R
    J Virol; 2013 May; 87(10):5895-903. PubMed ID: 23487470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination capacity of a TSE-model agent in the manufacturing process of Alphanate/Fanhdi, a human factor VIII/VWF complex concentrate.
    Diez JM; Caballero S; Belda FJ; Otegui M; Gajardo R; Jorquera JI
    Haemophilia; 2009 Nov; 15(6):1249-57. PubMed ID: 19563480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary excretion and blood level of prions in scrapie-infected hamsters.
    Murayama Y; Yoshioka M; Okada H; Takata M; Yokoyama T; Mohri S
    J Gen Virol; 2007 Oct; 88(Pt 10):2890-2898. PubMed ID: 17872544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptation and selection of prion protein strain conformations following interspecies transmission of transmissible mink encephalopathy.
    Bartz JC; Bessen RA; McKenzie D; Marsh RF; Aiken JM
    J Virol; 2000 Jun; 74(12):5542-7. PubMed ID: 10823860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capacity of the manufacturing process of Flebogamma(®) DIF, a new human high purity intravenous immunoglobulin, to remove a TSE model-agent.
    Diez JM; Caballero S; Belda F; Otegui M; Gajardo R; Jorquera JI
    Biologicals; 2010 Nov; 38(6):670-4. PubMed ID: 20863716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biology of non-conventional transmissible agents or prions].
    Dormont D
    Rev Neurol (Paris); 1998 Feb; 154(2):142-51. PubMed ID: 9773035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prion infectivity is encoded exclusively within the structure of proteinase K-resistant fragments of synthetically generated recombinant PrP
    Wang F; Wang X; Abskharon R; Ma J
    Acta Neuropathol Commun; 2018 Apr; 6(1):30. PubMed ID: 29699569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectivity-associated PrP(Sc) and disease duration-associated PrP(Sc) of mouse BSE prions.
    Miyazawa K; Okada H; Masujin K; Iwamaru Y; Yokoyama T
    Prion; 2015; 9(5):394-403. PubMed ID: 26555211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An improved Western blot assay to assess the clearance of prion protein from plasma-derived therapeutic proteins.
    Hartwell RC; Nelson MS; Kislan MM; Stenland CJ; Miller JL; Pifat DY; Petteway SR; Cai K
    J Virol Methods; 2005 May; 125(2):187-93. PubMed ID: 15794989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of PrP in extraneural tissues.
    Brown KL; Ritchie DL; McBride PA; Bruce ME
    Microsc Res Tech; 2000 Jul; 50(1):40-5. PubMed ID: 10871547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PrP P102L and Nearby Lysine Mutations Promote Spontaneous
    Kraus A; Raymond GJ; Race B; Campbell KJ; Hughson AG; Anson KJ; Raymond LD; Caughey B
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety evaluation for a biodiesel process using prion-contaminated animal fat as a source.
    Seidel B; Alm M; Peters R; Kördel W; Schäffer A
    Environ Sci Pollut Res Int; 2006 Mar; 13(2):125-30. PubMed ID: 16612902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in infectivity of endogenous transmissible spongiform encephalopathies present in blood by adsorption to selective affinity resins.
    Gregori L; Gurgel PV; Lathrop JT; Edwardson P; Lambert BC; Carbonell RG; Burton SJ; Hammond DJ; Rohwer RG
    Lancet; 2006 Dec; 368(9554):2226-30. PubMed ID: 17189034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.